{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:28:42Z","timestamp":1762086522598,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T00:00:00Z","timestamp":1644105600000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ando.2020.11.007","type":"journal-article","created":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T10:44:14Z","timestamp":1607165054000},"page":"59-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Adherence to growth hormone therapy guidelines in a real-world French cohort of adult patients with growth hormone deficiency"],"prefix":"10.1016","volume":"82","author":[{"given":"Fran\u00e7oise","family":"Borson-Chazot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Chabre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Salenave","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aude","family":"Brac de la Perriere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Reznik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Kerlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evguenia","family":"Hacques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9atrice","family":"Villette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2016","series-title":"Growth hormone deficiency","author":"Genetic and Rare Disease Information Center","key":"10.1016\/j.ando.2020.11.007_bib0140"},{"key":"10.1016\/j.ando.2020.11.007_bib0145","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fendo.2013.00064","article-title":"Adult growth hormone deficiency \u2013 benefits, side effects, and risks of growth hormone replacement","volume":"4","author":"Reed","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2020.11.007_bib0150","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: An Endocrine Society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.11.007_bib0155","first-page":"1575","article-title":"The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender","volume":"81","author":"Johannsson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"year":"2015","series-title":"Non-interventional study abstract for external disclosure","author":"Kabi International Metabolic Survey (KIMS\u00ae) (Pfizer International Metabolic Database)","key":"10.1016\/j.ando.2020.11.007_bib0160"},{"key":"10.1016\/j.ando.2020.11.007_bib0165","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11102-013-0529-6","article-title":"Adult mortality or morbidity is not increased in childhood-onset growth hormone deficient patients who received pediatric GH treatment: an analysis of the Hypopituitary Control and Complications Study (HypoCCS)","volume":"17","author":"Mo","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/j.ando.2020.11.007_bib0170","doi-asserted-by":"crossref","first-page":"E213","DOI":"10.1210\/jc.2011-2882","article-title":"Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study","volume":"97","author":"Savendahl","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.11.007_bib0175","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/cen.13502","article-title":"Long-term safety of growth hormone-A combined registry analysis","volume":"88","author":"Stochholm","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2020.11.007_bib0180","doi-asserted-by":"crossref","unstructured":"Beck-Peccoz P, H\u00f6ybye C, Murray R, Simsek S, Zabransky M, Zouater H, et al. Latest safety outcomes from the PATRO adults study of Omnitrope\u00ae for the treatment of adult patients with growth hormone deficiency [abstract]. Presented at: 20th European Congress of Endocrinology; 19-22 May 2018; Barcelona, Spain.[Abstract P749].","DOI":"10.1530\/endoabs.56.P749"},{"key":"10.1016\/j.ando.2020.11.007_bib0185","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1530\/EJE-09-0247","article-title":"The value of IGF1 estimation in adults with GH deficiency","volume":"161","author":"Mukherjee","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2020.11.007_bib0190","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.11.007_bib0195","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s11102-011-0343-y","article-title":"How useful are serum IGF-I measurements for managing GH replacement therapy in adults and children?","volume":"15","author":"Pawlikowska-Haddal","year":"2012","journal-title":"Pituitary"},{"year":"2003","series-title":"Committee for proprietary medicinal products (CPMP) opinion following an article 7(5) referal. Norditropin","key":"10.1016\/j.ando.2020.11.007_bib0200"},{"key":"10.1016\/j.ando.2020.11.007_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ghir.2007.07.004","article-title":"Diagnosis of adult GH deficiency","volume":"18","author":"Ghigo","year":"2008","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.ando.2020.11.007_bib0210","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00638","article-title":"Diagnosis of Idiopathic GHD in Children Based on Response to rhGH Treatment: The Importance of GH Provocative Tests and IGF-1","volume":"10","author":"Fel\u00edcio","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.ando.2020.11.007_bib0215","first-page":"E1009","article-title":"Dose-response study of GH effects on circulating IGF-I and IGFBP-3 levels in healthy young men and women","volume":"276","author":"Ghigo","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ando.2020.11.007_bib0220","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/cen.13330","article-title":"Is GH dosing optimal in female patients with adult-onset GH deficiency? An analysis from the NordiNet\u00ae International Outcome Study","volume":"86","author":"H\u00f6ybye","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2020.11.007_bib0225","first-page":"379","article-title":"Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency","volume":"83","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.11.007_bib0230","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1210\/jc.2003-030204","article-title":"Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study","volume":"88","author":"Underwood","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.11.007_bib0235","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s00198-011-1854-0","article-title":"Growth hormone effects on cortical bone dimensions in young adults with childhood-onset growth hormone deficiency","volume":"23","author":"Hyldstrup","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ando.2020.11.007_bib0240","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1530\/eje.0.1370146","article-title":"The effects of two doses of replacement growth hormone on the biochemical, body composition and psychological profiles of growth hormone-deficient adults","volume":"137","author":"Carroll","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2020.11.007_bib0245","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1210\/jc.2007-2371","article-title":"Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study","volume":"93","author":"Beauregard","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.11.007_bib0250","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/cen.13958","article-title":"Prevalence of low lean mass in patients with adult growth hormone deficiency with or without low-dose growth hormone therapy","volume":"90","author":"Zheng","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2020.11.007_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ghir.2010.10.005","article-title":"The benefit of long-term growth hormone (GH) replacement therapy in hypopituitary adults with GH deficiency: results of the German KIMS database","volume":"21","author":"Spielhagen","year":"2011","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.ando.2020.11.007_bib0260","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s40618-016-0604-8","article-title":"Long-term safety and efficacy of Omnitrope\u00ae in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study","volume":"40","author":"Ferone","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.ando.2020.11.007_bib0265","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2265.1998.00439.x","article-title":"Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults","volume":"48","author":"Kann","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2020.11.007_bib0270","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/eje.1.02317","article-title":"Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency","volume":"156","author":"G\u00f6therstr\u00f6m","year":"2007","journal-title":"Eur J Endocrinol"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000342662031310X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000342662031310X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:25:11Z","timestamp":1762086311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000342662031310X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S000342662031310X"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2020.11.007","relation":{},"ISSN":["0003-4266"],"issn-type":[{"type":"print","value":"0003-4266"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence to growth hormone therapy guidelines in a real-world French cohort of adult patients with growth hormone deficiency","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2020.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}